3 results
Approved WMOCompleted
To assess the efficacy of the co-administration of lanreotide Autogel 120 mg(administered via deep sub-cutaneous injections every 28 days) and pegvisomant(administered at 40 to 120 mg per week via sub-cutaneous injection given once ortwice a week)…
Esophageal stent BD-Covered for refractory benign esophageal strictures: a safety and efficacy study
The main objective of this study is to evaluate, in an exploratory study, the safety and efficacy of implanting the Esophageal Stent BD-Covered (BD-Covered) in patients with refractory benign esophageal strictures, i.e. who has been treated with a…
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.